FDA Approves First Cream for Treating Chronic Hand Eczema, Anzupgo - Drugs.com MedNews THURSDAY, July 24, 2025 The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczem

🧴 FDA approves #Anzupgo - first cream specifically for chronic hand eczema! Game-changer for 10% of Americans suffering from this painful condition when steroids fail. Targets JAK enzymes causing inflammation. #HandEczema #FDAApproval www.drugs.com/news/fda-app...

Weekly Roundup - PHARMA - 10 February 2025 🔊Celltrion’s Avtozma Wins FDA Approval for Autoimmune & Inflammatory Diseases Avtozma, an Actemra biosimilar, is approved in both IV and SC forms, backed by a Phase III trial confirming its similarity...

Weekly Roundup - PHARMA - 10 February 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#Celltrion #Avtozma #Axsome #Symbravo #Anzupgo #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand

MHRA grants marketing authorisation for LEO Pharma’s eczema cream - Pf Media The MHRA has granted marketing authorisation for LEO Pharma’s cream for the treatment of patients with moderate to severe chronic hand eczema.

#dermatology #skindisease #MHRA #Anzupgo #delgocitinib #eczemacream #handeczema #chronichandeczema #LEOPharma #UKMHRA #topicalJAKinhibitor #JAKinhibitor #phase3clincialtrials #DELTA1clincialtrial #DELTA2clinicaltrial #DELTA3openlabelextensiontrial #NICE #NHS
pf-media.co.uk/news/mhra-gr...